Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
vFinance Investments, Inc. was a full-service investment banking and brokerage firm that specialized in providing financial services to micro, small, and mid-cap high-growth companies, with a significant focus on the biotechnology and healthcare sectors. Originally a subsidiary of vFinance, Inc., the firm merged with National Holdings Corporation in 2008 and later became part of the Fortress Biotech ecosystem when Fortress acquired a controlling interest in National Holdings in 2016. The firm provided a range of services including retail brokerage, investment banking, M&A advisory, and market-making for thousands of micro-cap stocks. In 2018, vFinance Investments was consolidated into National Securities Corporation as part of a corporate restructuring. Its legacy is closely tied to the financing of early-stage life science companies and the strategic expansion of its parent company's healthcare investment banking division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on vFinance Investments.